文献速递腹部MR

细胞外对比剂增强MRI:15分钟延迟期可能提高慢性肝病患者肝细胞癌的诊断效能

Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease.
PubMed 文献 · Eur Radiol · 2017-11-13

研究纳入2014至2015年间103例慢性肝病患者的133个病灶(107个肝细胞癌、23个良性病灶、3个非肝细胞癌恶性肿瘤),评估细胞外对比剂增强MRI加做15分钟延迟期的价值。两位腹部放射科医师分别按EASL和LI-RADS标准判读,加做15分钟延迟期后分别多诊断3或4个肝细胞癌, reviewer 1敏感度从69.2%升至72.0%(P=0.072),reviewer 2从75.7%升至79.4%(P=0.041),23个良性病灶未见额外发现。结论认为加做15分钟延迟期可能提高慢性肝病患者肝细胞癌的诊断效能。

要点

  • 约5%的肝细胞癌仅在15分钟延迟期显示廓清或包膜表现。
  • 加做15分钟延迟期后,reviewer 1敏感度从69.2%升至72.0%(P=0.072),reviewer 2从75.7%升至79.4%(P=0.041)。
  • 23个良性病灶在15分钟延迟期未见额外发现。

核心结论

  • 在细胞外对比剂增强MRI中加入15分钟延迟期可能提高慢性肝病患者肝细胞癌的诊断效能。

研究设计与样本

  • 2014至2015年间纳入103例慢性肝病患者的133个病灶(107个肝细胞癌、23个良性病灶、3个非肝细胞癌恶性肿瘤),以病理或临床诊断为标准,由两位腹部放射科医师独立按EASL和LI-RADS标准判读。

关键影像表现/征象

  • 约5%的肝细胞癌仅在15分钟延迟期显示廓清或包膜表现。
  • 23个良性病灶在15分钟延迟期未见额外发现。

诊断标准与关键数值

  • 按EASL标准,加做15分钟延迟期后reviewer 1多诊断3个肝细胞癌,敏感度从69.2%升至72.0%(P=0.072)。
  • 按EASL标准,加做15分钟延迟期后reviewer 2多诊断4个肝细胞癌,敏感度从75.7%升至79.4%(P=0.041)。
  • 按LI-RADS标准,reviewer 1将1个肝细胞癌从LR-4升级为LR-5,reviewer 2将4个肝细胞癌从LR-4升级为LR-5。

临床应用与阅片要点

  • 在细胞外对比剂增强MRI中加做15分钟延迟期约需额外20秒采集时间。
  • 上述结果仅适用于慢性肝病患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine the value of a 15-min delayed phase in extracellular contrast agent (ECA)-enhanced magnetic resonance imaging (MRI) for evaluation of hepatocellular carcinoma (HCC) in patients with chronic liver disease.

METHODS: Between 2014 and 2015, 103 patients with chronic liver disease underwent ECA-enhanced MRI; 133 lesions consisting of 107 HCCs, 23 benign lesions and three non-HCC malignancies were identified with pathological or clinical diagnosis. MRI images were reviewed by two abdominal radiologists independently using the European Association for the Study of the Liver (EASL) and Liver Imaging Reporting and Data System (LI-RADS) criteria. Imaging features observed in the 15-min delayed phase were recorded.

RESULTS: Of 107 HCCs, three or four additional HCCs were diagnosed according to the EASL criteria by adding the 15-min delayed phase, increasing sensitivity (Reviewer 1, from 69.2-72.0 % [P = 0.072]; Reviewer 2, from 75.7-79.4 % [P = 0.041]). Reviewers 1 and 2 upgraded one and four HCCs from LR-4 to LR-5 based on the LI-RADS, respectively. Among 23 benign lesions, no additional findings were observed in the 15-min delayed phase.

CONCLUSIONS: Including the 15-min delayed phase in ECA-enhanced MRI may improve the diagnostic performance for HCC in patients with chronic liver disease.

KEY POINTS: • Additional acquisition of 15-min delayed phase (FDP) requires approximately 20 s. • About 5 % of HCCs show washout or capsule appearance only in FDP. • Including FDP improves the sensitivity of extracellular contrast agent-enhanced MRI for HCC. • These results are applicable only to patients with chronic liver disease.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lee SE, An C, Hwang SH, et al. Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease. Eur Radiol. 2017. PMID: 29134355. doi:10.1007/s00330-017-5119-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。